Hybridoma obtained by fusing mouse myeloma cells (NS-1) with BALB/c mouse spleen cells immunized with prostatic acid phosphatase (PAP) derived from human prostatic cancer tissue is proliferated in the BALB/c mouse abdominal cavity and ascites is collected.
Specificity:
This monoclonal antibody specifically reacts with human PAP.